• Datwyler supplies high-quality, system-critical components for the packaging of COVID-19 vaccines to BioNTech, Serum Institute of India and several other vaccine providers.
  • Expanded network of FirstLine™ manufacturing facilities helped meet demand for system-critical packaging components.
  • Accelerated scale-up and 24/7 production in the Datwyler plants around the world significantly increased the production capacities.
  • Datwyler invests in expanding production capacities for healthcare plants globally to better meet demand for critical components used in vaccine development and beyond.

Attachments

  • Original document
  • Permalink

Disclaimer

Dätwyler Holding AG published this content on 14 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 14:25:04 UTC.